hydrocortamate (magnacort) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now
Hydrocortamate is a synthetic glucocorticoid possessing anti-inflammatory properties and acting as a glucocorticoid receptor agonist. Hydrocortamate was used under the brand name Magnacor to treat inflammation due to corticosteroid-responsive dermatoses btut that usage has been discontinued.   NCATS

Chemistry

  • SMILES: CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
  • InChIKey: FWFVLWGEFDIZMJ-FOMYWIRZSA-N
  • Mol. Mass: 475.63
  • ALogP: 2.67
  • ChEMBL Molecules:
    hydrocortamate  
    hydrocortamate hydrochloride  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Topical
  • Pro Drug: No

Alternative names

17-hydroxycorticosterone, 21-(diethylamino)acetate | ethamicort | hidrocortamato | hydrocortamate | hydrocortamate chloride | hydrocortamate hcl | hydrocortamate hydrochloride | hydrocortamatum | magnacort

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Skin Diseases

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue